Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The QT Imaging Holdings, Inc. (QTIH) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports, registration statements, and related exhibits. QT Imaging is a medical device company in the healthcare sector that develops and commercializes body imaging systems using low frequency sound waves, and its filings offer detailed insight into its capital structure, financing arrangements, and operational progress.
Investors can review Form 8-K current reports where QT Imaging discloses material events such as private placement (PIPE) financings, warrant repurchases, amendments to credit agreements, and the implementation of a 3:1 reverse stock split of its common stock. Certain 8-K filings also furnish unaudited pro forma condensed consolidated financial statements, which show how transactions like the September 2025 private placement and subsequent debt repayments affect the company’s balance sheet and statements of operations.
The company has filed a Form S-1 registration statement and an amended Form S-1/A, which contain information about its securities, historical financial statements, and various equity and debt instruments, including warrants, convertible notes, bridge loans, and earnout arrangements. These documents, together with other periodic and transactional filings, outline QT Imaging’s status as an emerging growth company and describe key elements of its financing history and customer concentration.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries help explain the significance of complex disclosures, highlighting items such as changes to rights of security holders, reverse stock split mechanics, private placement terms, and pro forma adjustments. Users can quickly locate quarterly and annual financial information within registration statements, track capital markets actions, and examine how QT Imaging reports on its imaging business, cloud platform development, and related risks in its official SEC documents.
QT Imaging Holdings, Inc. received an updated ownership report from investment firm Lynrock Lake entities and Cynthia Paul. As of December 31, 2025, they beneficially owned 1,154,586 shares of QT Imaging common stock, representing 9.7% of the outstanding shares based on 11,902,198 shares reported outstanding.
The shares are directly held by Lynrock Lake Master Fund LP, with voting and investment power delegated to Lynrock Lake LP as investment manager and influenced by Cynthia Paul through her roles at the related entities. Lynrock Lake Master also holds warrants that are currently restricted by approximately 4.9% beneficial ownership limits. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of QT Imaging.
QT Imaging Holdings, Inc. updates its S-1 covering 29,336,017 shares of common stock by incorporating three recent developments. The company signed an exclusive distribution agreement with Al Naghi Medical Co. to market and sell its breast imaging scanners and cloud platform in the United Arab Emirates through January 19, 2029, subject to minimum purchase requirements. It completed a January 2026 private placement with its board chairman, issuing 24,107 shares at $6.43 plus a 10‑year warrant for up to 48,214 additional shares, raising about $155,002 for working capital and granting registration rights. Pro forma information also reflects an earlier October 2025 private placement of about $18.18 million and repayment of about $5.36 million of debt and related amounts. In addition, Nasdaq approved the company’s common stock for listing on the Nasdaq Capital Market under the symbol “QTI”, with trading expected to begin on January 28, 2026.
QT Imaging Holdings, Inc. reports that Nasdaq has approved the listing of its common stock on the Nasdaq Capital Market. The shares are expected to begin trading under the ticker symbol “QTI” on January 28, 2026, moving from a prior trading venue not described here.
The company highlights that this uplisting remains subject to meeting Nasdaq’s ongoing listing standards and pairs the news with an extensive caution about forward-looking statements. It notes risks around successfully commercializing its QT Imaging Breast Acoustic CT™ Scanner, expanding product offerings, securing financing, addressing a material weakness in internal controls, and meeting business milestones. A press release announcing the uplisting is filed as Exhibit 99.1.
QT Imaging Holdings chairman Avi Katz reported new purchases of company securities. On January 22, 2026, he bought 24,107 shares of common stock at $6.43 per share, bringing his directly held common stock to 413,452 shares, adjusted for a 3-for-1 reverse stock split effected on October 23, 2025.
On the same date, he also purchased 48,214 private warrants with a $6.43 exercise price. Each warrant is exercisable for one share of common stock starting July 22, 2026 and expiring on July 22, 2036. Following these transactions, he directly holds 48,214 private warrants in addition to his common shares.
QT Imaging Holdings, Inc. entered into a private placement on January 22, 2026 with its board chairman, Dr. Avi Katz. The company sold 24,107 shares of common stock at $6.43 per share, a price equal to 110% of the 5-day volume-weighted average, and issued a 10-year warrant to purchase up to 48,214 additional shares at the same exercise price. Gross proceeds were about $155,002, which the company plans to use for working capital.
The parties signed a Securities Purchase Agreement and a Registration Rights Agreement. QT Imaging agreed to register the resale of the purchased shares and warrant shares within specified deadlines, with cash liquidated damages of 0.5% of the subscription amount per month if certain resale-blocking events occur. The company also filed unaudited pro forma financial information reflecting this transaction, an earlier October 2025 private placement of approximately $18,180,655, and repayment of $5,360,477 of debt to Lynrock Lake Master Fund LP as if these occurred on January 1, 2025.
QT Imaging Holdings, Inc. entered into an exclusive distribution agreement with Al Naghi Medical Co. for the United Arab Emirates. Al Naghi receives exclusive rights to market, advertise and sell QT Breast Acoustic CT Scanners and QTI Cloud Platform SaaS subscriptions in the territory, while QT Imaging retains all intellectual property rights and provides training and professional services.
The agreement runs from January 19, 2026 through January 19, 2029, with an automatic one-year extension if specified minimum purchase and revenue targets are met. If Al Naghi does not meet these minimum requirements in any year, QT Imaging may either end exclusivity in the UAE or terminate the agreement. Al Naghi handles regulatory clearances, logistics, shipping costs and local taxes, and typically pays 50% of each order at placement and 50% within 45 days of shipment. QT Imaging offers limited product warranties ranging from at least one year up to five years, depending on client purchase price.
QT Imaging Holdings, Inc. is registering 29,336,017 shares of common stock for resale by existing securityholders. These shares include 2,562,334 already issued shares and 26,773,683 shares issuable upon exercise of various five-year, ten-year and pre‑funded warrants.
The company will not receive proceeds from resales, but would receive cash if warrants are exercised. As of December 26, 2025, 11,902,198 shares were outstanding, which would rise to 38,667,630 shares if all registered warrants are exercised for cash. The shares stem from prior private placements that raised about $18.9 million and from a senior secured term loan and warrant package with Lynrock Lake totaling $15.1 million in principal.
QT Imaging develops low‑energy sound breast imaging technology, led by its QT Breast Scanner and QTviewer software, and has distribution and manufacturing agreements with Canon-related entities and partners in the U.S. and Saudi Arabia. The prospectus highlights substantial historical losses, significant future capital needs, potential stock overhang from large registered resales, and numerous operational and regulatory risks.
QT Imaging Holdings, Inc. has filed an amended shelf registration to permit the resale of up to 29,336,017 shares of common stock by existing investors. These shares include 2,562,334 shares already issued and additional shares issuable from various five-year, ten-year and pre-funded warrants tied to prior financing transactions.
The company recently effected a 3:1 reverse stock split, approved in August 2025 and effective in October 2025, which adjusted outstanding warrants and share counts. It also entered into a senior secured term loan credit agreement with Lynrock Lake for an aggregate principal amount of $15,100,000, accompanied by a large common stock warrant adjusted to 20,333,623 shares at a $1.20 exercise price after the reverse split.
In 2025 the company completed three private placements raising gross proceeds of approximately $500,000, $200,000 and $18,180,655, issuing common shares and warrants now being registered for resale. QT Imaging will not receive proceeds from investors’ resale of these shares but may receive cash if the registered warrants are exercised. The prospectus also describes exclusive distribution agreements for its QT Breast Scanner in the U.S. and Saudi Arabia and a manufacturing agreement with Canon Medical Systems Corporation.